{
    "ucits": true,
    "type": "ETF",
    "leverage": false,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "physical",
    "complex_factors": "Use of derivatives for index replication and efficient portfolio management; exposure to OTC derivatives with counterparty risk mitigated by collateral; investment in bonds including structured notes; no securities lending; no leverage beyond UCITS limits",
    "classification": "complex",
    "supporting_data": "The fund is a UCITS ETF investing predominantly in bonds and transferable securities, tracking the Bloomberg US 1-3 Year Treasury Bond Index. It uses derivatives, including OTC derivatives, to gain exposure where direct replication is not practicable or to generate efficiencies. The use of OTC derivatives introduces counterparty risk, although mitigated by a collateral policy. The ETF does not engage in securities lending and does not use significant leverage beyond UCITS limits. The replication method is physical or optimized physical, but derivatives are integral to achieving the investment objective. According to MiFID II Article 25(4)(a)(iv) and Article 57 of the Commission Delegated Regulation, UCITS ETFs are generally non-complex unless they embed derivatives or structured products that introduce complexity. The presence of derivatives integral to the strategy, OTC counterparty risk, and structured notes exposure means the ETF fails the non-complex criteria under Article 57, making it complex. ESMA guidance and CESR advice confirm that ETFs using derivatives centrally, especially OTC derivatives with counterparty risk, are complex. Therefore, despite being a UCITS ETF, this fund is classified as complex under MiFID II appropriateness rules and requires an appropriateness assessment for non-advised retail investors."
}